- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Malignant Hyperthermia
Total 5267 results
-
University of UtahTerminatedMalignant NeoplasmUnited States
-
SanofiActive, not recruitingNeoplasm MalignantUnited States, Canada, France, Korea, Republic of, Spain
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
LaNova Medicines LimitedSuspendedMalignant TumorsChina
-
Tianjin Chasesun Pharmaceutical Co., LTDEnrolling by invitation
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMalignant NeoplasmUnited States
-
Bristol-Myers SquibbCompletedMalignant Solid TumorUnited States, France, Italy, Australia, Canada, Germany, Netherlands
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
First People's Hospital of HangzhouCompletedMalignant Biliary ObstructionChina
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMalignant NeoplasmUnited States
-
Roswell Park Cancer InstituteTerminatedMalignant NeoplasmUnited States
-
SanofiCompletedNeoplasm MalignantSpain, Belgium, United States, France
-
NatureWise Biotech & Medicals CorporationCompletedMalignant NeoplasmUnited States
-
Nektar TherapeuticsCompletedMalignant Solid TumorUnited States, Belgium
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedMalignant NeoplasmUnited States
-
Gary MorrowNational Cancer Institute (NCI)CompletedMalignant NeoplasmUnited States
-
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)Pharmaceutical Research AssociatesUnknown
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Conquer Cancer FoundationCompleted
-
Jonsson Comprehensive Cancer CenterTerminatedMalignant NeoplasmUnited States
-
Li YuUnknownMalignant NeoplasmChina
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedMalignant NeoplasmUnited States
-
Medical University of ViennaUnknown
-
SanofiMerck KGaA, Darmstadt, GermanyCompletedNeoplasm MalignantNetherlands, France
-
SanofiCompletedNeoplasm MalignantKorea, Republic of, Japan
-
Yonsei UniversityCompletedMalignant Biliary ObstructionKorea, Republic of
-
SanofiRegeneron PharmaceuticalsCompleted
-
SanofiCompletedNeoplasm MalignantBelgium, United States
-
SanofiRegeneron PharmaceuticalsCompletedNeoplasm MalignantChina
-
SanofiCompletedNeoplasms, MalignantUnited States, Belgium, Denmark, Netherlands, Sweden
-
European Institute of OncologyRecruiting
-
Peking Union Medical College HospitalRecruiting
-
Peking Union Medical College HospitalPeking University; Peking University Cancer Hospital & InstituteRecruiting
-
Biotheus Inc.Recruiting
-
Chinese University of Hong KongNot yet recruiting
-
Zagazig UniversityRecruitingMalignant Biliary ObstructionEgypt
-
Wuhan Union Hospital, ChinaRecruiting
-
Icahn School of Medicine at Mount SinaiM.D. Anderson Cancer Center; Emory UniversityRecruitingMalignant NeoplasmsUnited States
-
Seoul National University HospitalRecruitingMalignant Biliary ObstructionKorea, Republic of
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)RecruitingMalignant Solid NeoplasmUnited States
-
Pennington Biomedical Research CenterRecruitingNeoplasm MalignantUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingMalignant Solid NeoplasmUnited States
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingNon-Malignant NeoplasmUnited States
-
Akesobio Australia Pty LtdRecruitingNeoplasms MalignantAustralia
-
NRG OncologyNational Cancer Institute (NCI)RecruitingMalignant Solid NeoplasmUnited States, Puerto Rico
-
University of Southern CaliforniaNational Cancer Institute (NCI)Recruiting
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyRecruitingMalignant NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingMalignant NeoplasmUnited States